Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Cignarella

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Nature Reviews. Endocrinology|May 22, 2026
Aldosterone synthase inhibitors for the treatment of cardiovascular diseaseGian Paolo Rossi, Federico Bernardo Rossi, Andrea Cignarella, et al.
Life Sciences|October 1, 2023
MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPERCarlotta Boscaro, Giovanni Eugenio Ramaschi, Lucia Trevisi, et al.
Pharmacological Research|October 11, 2023
Sex-oriented perspectives in immunopharmacologyAndrea Cignarella, Elisabetta Vegeto, Chiara Bolego, et al.
Circulation|June 25, 2003
Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-betaAdriana Maggi, Andrea Cignarella, Alessia Brusadelli, et al.
International Journal of Molecular Sciences|March 16, 2018
Estrogen, Angiogenesis, Immunity and Cell Metabolism: Solving the PuzzleAnnalisa Trenti, Serena Tedesco, Carlotta Boscaro, et al.
Biochemical Pharmacology|June 12, 2018
Effects of digitoxin on cell migration in ovarian cancer inflammatory microenvironmentAnnalisa Trenti, Carlotta Boscaro, Serena Tedesco, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal TolerabilityGian Paolo Fadini, Mario Luca Morieri, Carlotta Boscaro, et al.
Biochemical Pharmacology|February 11, 2024
The antiangiogenic effect of digitoxin is dependent on a ROS-elicited RhoA/ROCK pathway activationCarlotta Boscaro, Gudula Schimdt, Andrea Cignarella, et al.
Frontiers in Pharmacology|January 4, 2021
Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK ActivationCarlotta Boscaro, Annalisa Trenti, Chiara Baggio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 2, 2022
Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulationCarlotta Boscaro, Chiara Baggio, Marcello Carotti, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Nature Reviews. Endocrinology|May 22, 2026
Aldosterone synthase inhibitors for the treatment of cardiovascular diseaseGian Paolo Rossi, Federico Bernardo Rossi, Andrea Cignarella, et al.
Life Sciences|October 1, 2023
MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPERCarlotta Boscaro, Giovanni Eugenio Ramaschi, Lucia Trevisi, et al.
Pharmacological Research|October 11, 2023
Sex-oriented perspectives in immunopharmacologyAndrea Cignarella, Elisabetta Vegeto, Chiara Bolego, et al.
Circulation|June 25, 2003
Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-betaAdriana Maggi, Andrea Cignarella, Alessia Brusadelli, et al.
International Journal of Molecular Sciences|March 16, 2018
Estrogen, Angiogenesis, Immunity and Cell Metabolism: Solving the PuzzleAnnalisa Trenti, Serena Tedesco, Carlotta Boscaro, et al.
Biochemical Pharmacology|June 12, 2018
Effects of digitoxin on cell migration in ovarian cancer inflammatory microenvironmentAnnalisa Trenti, Carlotta Boscaro, Serena Tedesco, et al.
Diabetes, Obesity & Metabolism|May 10, 2026
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal TolerabilityGian Paolo Fadini, Mario Luca Morieri, Carlotta Boscaro, et al.
Biochemical Pharmacology|February 11, 2024
The antiangiogenic effect of digitoxin is dependent on a ROS-elicited RhoA/ROCK pathway activationCarlotta Boscaro, Gudula Schimdt, Andrea Cignarella, et al.
Frontiers in Pharmacology|January 4, 2021
Sex Differences in the Pro-Angiogenic Response of Human Endothelial Cells: Focus on PFKFB3 and FAK ActivationCarlotta Boscaro, Annalisa Trenti, Chiara Baggio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 2, 2022
Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulationCarlotta Boscaro, Chiara Baggio, Marcello Carotti, et al.
Pageof 8